IL269123A - שיטות לטיפול בסרטן - Google Patents
שיטות לטיפול בסרטןInfo
- Publication number
- IL269123A IL269123A IL26912319A IL26912319A IL269123A IL 269123 A IL269123 A IL 269123A IL 26912319 A IL26912319 A IL 26912319A IL 26912319 A IL26912319 A IL 26912319A IL 269123 A IL269123 A IL 269123A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- treating cancer
- cancer
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762468259P | 2017-03-07 | 2017-03-07 | |
PCT/US2017/052663 WO2018164715A1 (en) | 2017-03-07 | 2017-09-21 | Methods of treating cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL269123A true IL269123A (he) | 2019-11-28 |
Family
ID=63447943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL26912319A IL269123A (he) | 2017-03-07 | 2019-09-04 | שיטות לטיפול בסרטן |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3592357A4 (he) |
JP (1) | JP7042836B2 (he) |
KR (1) | KR20190122251A (he) |
CN (1) | CN110430882A (he) |
AU (1) | AU2017402623A1 (he) |
CA (1) | CA3055308A1 (he) |
IL (1) | IL269123A (he) |
TW (1) | TW201832768A (he) |
WO (1) | WO2018164715A1 (he) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4402264A2 (en) * | 2021-09-16 | 2024-07-24 | Agency for Science, Technology and Research | Modulation of tjp1 expression to treat liver diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003225903A1 (en) * | 2002-03-21 | 2003-10-08 | Curagen Corporation | Methods of using farnesoid x receptor (fxr) agonists |
ES2523591T3 (es) | 2006-06-27 | 2014-11-27 | Intercept Pharmaceuticals Inc. | Derivados de ácidos biliares como ligandos de FXR para la prevención o el tratamiento de enfermedades o estados mediados por FXR |
WO2013037482A1 (en) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
CN104853758A (zh) | 2012-11-28 | 2015-08-19 | 英特赛普特医药品公司 | 肺部疾病的治疗 |
WO2015183794A1 (en) * | 2014-05-27 | 2015-12-03 | City Of Hope | Tgr5 agonist complexes for treating diabetes and cancer |
WO2016086115A1 (en) * | 2014-11-26 | 2016-06-02 | Enanta Pharmaceuticals, Inc. | Tetrazole derivatives of bile acids as fxr/tgr5 agonists and methods of use thereof |
PE20180690A1 (es) * | 2015-04-27 | 2018-04-23 | Intercept Pharmaceuticals Inc | Composiciones de acido obeticolico y metodos de uso |
EP3442946A4 (en) | 2016-04-13 | 2019-12-04 | Intercept Pharmaceuticals, Inc. | METHOD FOR THE TREATMENT OF CANCER |
-
2017
- 2017-08-11 TW TW106127326A patent/TW201832768A/zh unknown
- 2017-09-21 KR KR1020197029033A patent/KR20190122251A/ko unknown
- 2017-09-21 WO PCT/US2017/052663 patent/WO2018164715A1/en unknown
- 2017-09-21 JP JP2019548368A patent/JP7042836B2/ja active Active
- 2017-09-21 CN CN201780088500.7A patent/CN110430882A/zh active Pending
- 2017-09-21 CA CA3055308A patent/CA3055308A1/en not_active Abandoned
- 2017-09-21 EP EP17899634.4A patent/EP3592357A4/en not_active Withdrawn
- 2017-09-21 AU AU2017402623A patent/AU2017402623A1/en not_active Abandoned
-
2019
- 2019-09-04 IL IL26912319A patent/IL269123A/he unknown
Also Published As
Publication number | Publication date |
---|---|
JP7042836B2 (ja) | 2022-03-28 |
EP3592357A4 (en) | 2021-01-13 |
EP3592357A1 (en) | 2020-01-15 |
AU2017402623A1 (en) | 2019-09-26 |
JP2020510009A (ja) | 2020-04-02 |
CA3055308A1 (en) | 2018-09-13 |
KR20190122251A (ko) | 2019-10-29 |
TW201832768A (zh) | 2018-09-16 |
WO2018164715A1 (en) | 2018-09-13 |
CN110430882A (zh) | 2019-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275663A (he) | שיטות לטיפול בסרטן | |
IL269026A (he) | שיטות לטיפול בגידול | |
HK1258098A1 (zh) | 治療癌症的方法 | |
HK1251408A1 (zh) | 治療癌症的方法 | |
ZA201804227B (en) | Methods of treating cancer | |
IL262342A (he) | שיטות טיפול בסרטן | |
EP3606531A4 (en) | CANCER TREATMENT METHODS | |
IL264443A (he) | שיטות לטיפול בסרטן הערמונית | |
ZA201808258B (en) | Methods of treating pancreatic cancer | |
ZA201908539B (en) | Method of treatment of cancer | |
SG11202010793UA (en) | Methods of treating cancer | |
IL263835A (he) | טיפול מונחה–אקזוסום בסרטן | |
EP3487999A4 (en) | METHODS OF TREATING CANCER | |
IL277981A (he) | שיטות לטיפול בסרטן | |
SG11202005163PA (en) | Methods of treating cancer | |
IL281600A (he) | שיטות לטיפול בסרטן | |
GB201717945D0 (en) | Method for treatment of cancer | |
IL269123A (he) | שיטות לטיפול בסרטן | |
IL274748A (he) | טיפול משופר בסרטן | |
IL272379A (he) | שיטות לטיפול בסרטן באמצעות עיכוב setds | |
EP3442555A4 (en) | METHODS OF TREATING BREAST CANCER | |
EP3389670A4 (en) | METHODS OF TREATING BREAST CANCER | |
GB201702139D0 (en) | Methods of cancer treatment | |
GB201704287D0 (en) | Treatment of cancer | |
GB201703857D0 (en) | Treatment of cancer |